- Home
- AG vs RGC Comparison
AG vs RGC Comparison
Compare AG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$25.71
N/A
Current Price
$23.80
Company Overview
Basic Information| Metric | AG | RGC |
|---|---|---|
| Founded | 1979 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.5B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AG | RGC |
|---|---|---|
| Price | $25.71 | $23.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $21.92 | N/A |
| AVG Volume (30 Days) | ★ 19.1M | 101.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.75 | N/A |
| Revenue Next Year | $26.43 | N/A |
| P/E Ratio | $143.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.19 | $9.39 |
| 52 Week High | $32.00 | $950.00 |
Technical Indicators
Market Signals| Indicator | AG | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 43.10 |
| Support Level | $20.21 | $20.81 |
| Resistance Level | $27.90 | $26.42 |
| Average True Range (ATR) | 1.73 | 2.40 |
| MACD | -0.57 | -0.33 |
| Stochastic Oscillator | 12.64 | 18.13 |
Price Performance
Historical Comparison AG
RGC
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.